Literature DB >> 34134879

Trends in visits to substance use disorder treatment facilities in 2020.

Jonathan Cantor1, David Kravitz1, Mark Sorbero2, Barbara Andraka-Christou3, Christopher Whaley1, Kathryn Bouskill1, Bradley D Stein4.   

Abstract

OBJECTIVE: To describe weekly changes in the number of substance use disorder treatment (SUDT) facility visits in 2020 compared to 2019 using cell phone location data.
METHODS: We calculated the percentage weekly change in visits to SUDT facilities from the week of January 5 through the week of October 11, 2020, relative to the week of January 6 through the week of October 13, 2019. We stratified facilities by county COVID-19 incidence per 10,000 residents in each week and by 2018 fatal drug overdose rate. Finally, we conducted a multivariable linear regression analysis examining percent change in visits per week as a function of county-level COVID-19 tercile, a series of calendar month indicators, and the interaction of county-level COVID-19 tercile and month. We repeated the regression analysis replacing COVID-19 tercile with overdose tercile.
RESULTS: Beginning the eleventh week of 2020, the number of visits to SUDT facilities declined substantially, reaching a nadir of 48% of 2019 visits in early July. In contrast to January, there were significantly fewer visits in 2020 compared to 2019 in all subsequent months (p < 0.01 in all months). Multivariable regression results found that facilities in the tercile of counties experiencing the most COVID-19 cases had a significantly greater reduction in the number of SUDT visits in 2020 for the months of June through August than facilities in counties with the fewest COVID-19 rates (p < 0.05). The study found no statistically significant difference in the change in the number of visits by facilities in counties with historically different overdose rates. DISCUSSION: Our findings support the hypothesis that a reduction has occurred in the average weekly number of visits to SUDT facilities. The size of the effect differs based on the number of COVID-19 cases but not on historical overdose rate.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Disparities; Substance use disorder; Treatment

Mesh:

Year:  2021        PMID: 34134879      PMCID: PMC8217724          DOI: 10.1016/j.jsat.2021.108462

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  15 in total

1.  Neighbourhood income and physical distancing during the COVID-19 pandemic in the United States.

Authors:  Jonathan Jay; Jacob Bor; Elaine O Nsoesie; Sarah K Lipson; David K Jones; Sandro Galea; Julia Raifman
Journal:  Nat Hum Behav       Date:  2020-11-03

2.  Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.

Authors:  Thuy D Nguyen; Sumedha Gupta; Engy Ziedan; Kosali I Simon; G Caleb Alexander; Brendan Saloner; Bradley D Stein
Journal:  JAMA Intern Med       Date:  2021-04-01       Impact factor: 21.873

3.  Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas.

Authors:  Samrachana Adhikari; Nicholas P Pantaleo; Justin M Feldman; Olugbenga Ogedegbe; Lorna Thorpe; Andrea B Troxel
Journal:  JAMA Netw Open       Date:  2020-07-01

4.  Innovation During COVID-19: Improving Addiction Treatment Access.

Authors:  Elizabeth A Samuels; Seth A Clark; Caroline Wunsch; Lee Ann Jordison Keeler; Neha Reddy; Rahul Vanjani; Rachel S Wightman
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702

Review 5.  Strengths and weaknesses of existing data sources to support research to address the opioids crisis.

Authors:  Rosanna Smart; Courtney A Kase; Erin A Taylor; Susan Lumsden; Scott R Smith; Bradley D Stein
Journal:  Prev Med Rep       Date:  2019-11-06

6.  Timing of State and Territorial COVID-19 Stay-at-Home Orders and Changes in Population Movement - United States, March 1-May 31, 2020.

Authors:  Amanda Moreland; Christine Herlihy; Michael A Tynan; Gregory Sunshine; Russell F McCord; Charity Hilton; Jason Poovey; Angela K Werner; Christopher D Jones; Erika B Fulmer; Adi V Gundlapalli; Heather Strosnider; Aaron Potvien; Macarena C García; Sally Honeycutt; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-04       Impact factor: 17.586

7.  Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing.

Authors:  Jonathan Cantor; Bradley D Stein; Brendan Saloner
Journal:  J Addict Med       Date:  2020-12       Impact factor: 4.647

8.  Association of Mobile Phone Location Data Indications of Travel and Stay-at-Home Mandates With COVID-19 Infection Rates in the US.

Authors:  Song Gao; Jinmeng Rao; Yuhao Kang; Yunlei Liang; Jake Kruse; Dorte Dopfer; Ajay K Sethi; Juan Francisco Mandujano Reyes; Brian S Yandell; Jonathan A Patz
Journal:  JAMA Netw Open       Date:  2020-09-01
View more
  4 in total

Review 1.  Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments.

Authors:  Osnat C Melamed; Wayne K deRuiter; Leslie Buckley; Peter Selby
Journal:  Psychiatr Clin North Am       Date:  2021-11-12

2.  Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada.

Authors:  Kenneth A Feder; JinCheol Choi; Catherine G Schluth; Kanna Hayashi; Kora DeBeck; Michael-John Milloy; Gregory D Kirk; Shruti H Mehta; Michele Kipke; Richard D Moore; Marianna K Baum; Steven Shoptaw; Pamina M Gorbach; Brian Mustanski; Marjan Javanbakht; Suzanne Siminski; Becky L Genberg
Journal:  Drug Alcohol Depend       Date:  2022-06-24       Impact factor: 4.852

3.  Analysis of Substance Use Disorder Treatment Admissions in the US by Sex and Race and Ethnicity Before and During the COVID-19 Pandemic.

Authors:  Jonathan H Cantor; Christopher M Whaley; Bradley D Stein; David Powell
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data.

Authors:  Jonathan Cantor; Neeraj Sood; Dena M Bravata; Megan Pera; Christopher Whaley
Journal:  J Health Econ       Date:  2022-01-13       Impact factor: 3.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.